Newsfeeds - Spark Newswire

4 minute read

48 Biggest Movers From Yesterday

Today, 3:37 AM

Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding, Temporary.’ The company recently priced its IPO at $9 per unit.

AAMC

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 3:37 AM

ABSI

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 25, 2021

By Benzinga Insights

Today, 3:37 AM

AMBP

1 minute read

BTIG Initiates Coverage On Rani Therapeutics Hldgs with Buy Rating, Announces Price Target of $24

By Benzinga Newsdesk

Today, 3:37 AM

BTIG analyst Robert Hazlett initiates coverage on Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces Price Target of $24.

RANI

2 minute read

Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA

By Shanthi Rexaline

Today, 3:37 AM

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI), an early stage platform technology company that promotes oral dosing with its RaniPill, and RxSight, Inc.

RANI

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 24, 2021

By Benzinga Insights

Today, 3:37 AM

AGCO

1 minute read

B of A Securities Initiates Coverage On Rani Therapeutics Hldgs with Buy Rating, Announces Price Target of $23

By Benzinga Newsdesk

Today, 3:37 AM

B of A Securities initiates coverage on Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces Price Target of $23.

RANI

1 minute read

Cantor Fitzgerald Initiates Coverage On Rani Therapeutics Hldgs with Overweight Rating, Announces Price Target of $23

By Benzinga Newsdesk

Today, 3:37 AM

Cantor Fitzgerald analyst Brandon Folkes initiates coverage on Rani Therapeutics Hldgs (NASDAQ:RANI) with a Overweight rating and announces Price Target of $23.

RANI